Mainz Biomed N.V. (BST:4TO)
6.64
-0.10 (-1.48%)
Inactive · Last trade price on Dec 5, 2024
Mainz Biomed Employees
As of December 31, 2023, Mainz Biomed had 71 total employees, including 65 full-time and 6 part-time employees. The number of employees increased by 7 or 10.94% compared to the previous year.
Employees
71
Change (1Y)
7
Growth (1Y)
10.94%
Revenue / Employee
€12,589
Profits / Employee
€308,906
Market Cap
10.99M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 71 | 7 | 10.94% |
Dec 31, 2022 | 64 | - | - |
Mainz Biomed News
- 17 days ago - EQS-News: Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert - Wallstreet:Online
- 17 days ago - Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert® - GlobeNewsWire
- 26 days ago - Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants - GlobeNewsWire
- 5 weeks ago - Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewsWire
- 6 weeks ago - EQS-News: Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition - Wallstreet:Online
- 6 weeks ago - Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition - GlobeNewsWire
- 2 months ago - EQS-News: Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test - Wallstreet:Online
- 2 months ago - Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test - GlobeNewsWire